What are the best trades when a volatile market acts like 100 squirrels in a bag?
Pete Najarian: Big Pharma works. Merck (MRK) feels insulated, Genentech (DNA) will do well because of its pipeline. Biogen (BIIB) has limited downside.
Karen Finerman: Play defense with stocks like Altria (MO) and Kraft (KFT).
Guy Adami:Altria (MO), Unilever (UL) and Procter & Gamble (PG) are the best defensive plays.
Jeff Macke: Sell the pops and buy the drops in this tricky market.
Got something to say? Send us an e-mail at firstname.lastname@example.org and your comment might be posted on the Rapid Recap! Prefer to keep it between us? You can still send questions and comments to email@example.com.
Trader disclosure: On Nov. 20, 2007, the following stocks and commodities mentioned or intended to be mentioned on CNBC’s Fast Money were owned by the Fast Money traders: Macke Owns (YHOO), (EMC); Najarian Owns (AMTD) Options; (GOOG) Options; (YHOO) Options; Finerman's Firm And Finerman Own (GS), (KFT); Finerman's Firm Owns (SKS), (TSO), (WMT), (LTD), (CROX), Finerman's Firm Owns (MSFT) Options; Finerman's Firm Is Short (SPY), (IWM), (IYR), (IJR), (MDY), (LEN); Finerman's Firm Is Short (LEH) And Owns (LEH) Puts; Finerman's Firm Owns (HD) And (HD) Puts, Finerman Owns (HD); Finerman's Firm Owns S&P 500 Puts; Finerman's Firm Owns Russell 2000 Puts